News Focus
News Focus
icon url

theorysuit

12/11/24 10:56 PM

#736960 RE: learningcurve2020 #736959

They are grasping for straws with their dot connnecting.....gotta keep any kind of hope alive. Dot connector said between now and 1.31.25 based on this due diligence. Lmfao. Don't call mhra for what it is.... a rubber stamper. This is akin to what they call a hail Mary and prayer going to the UK with this convoluted data.
icon url

tunnelvisionofplenty

12/11/24 10:57 PM

#736961 RE: learningcurve2020 #736959

The FDA announced approval of vorasidenib on August 6, more than 5 weeks after the CHM meeting in question.

Typically one needs something sharp (e.g., needle, intellect) in order to burst a bubble.
icon url

dstock07734

12/11/24 11:09 PM

#736962 RE: learningcurve2020 #736959

How do you feel about the feedback from NICE? Did I burst your bubble?

https://www.nice.org.uk/Media/Default/About/what-we-do/Into-practice/NICE-resource-planner.xlsx

Topic routing was discussed at the NICE Prioritisation Board in October 2024. The Board concluded that the topic was suitable for a Technology Appraisal. Please see HST checklist on the project documents tab for further details.
The committee meeting is scheduled for 02 July 2025. More information will be provided as the development of the guidance progresses.





icon url

j e d

12/11/24 11:46 PM

#736970 RE: learningcurve2020 #736959

You said the June 2024 CHM meeting was “almost certainly for Vorasidenib,” but as of August 2024 an application hadn’t even been submitted for Vorasidenib. Hm.